HEALTH● LOW5d ago · Oct 8, 2026, 7:26 PM
Genentech's Tecentriq gains new indication for colon cancer
Seeking Alpha Tech · global
Genentech's drug Tecentriq has received a new indication for colon cancer. This development could expand treatment options for patients with this type of cancer.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH31m agoPope Leo is back on his feet after lung surgery and cancer diagnosisThe Independent WorldHEALTH31m agoKUHS Research Day: focus on geriatric care, indigenous medical devices, says ICMR officialThe HinduHEALTH44m agoPope walking and recovering 'as expected' after surgery, doctors sayBBC WorldHEALTH45m agoMicroplastics may produce harmful molecules if they enter our bloodNew Scientist